Effects of the Combination of Evogliptin and Leucine on Insulin Resistance and Hepatic Steatosis in High-Fat Diet-Fed Mice
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shin, Chang Yell | - |
dc.contributor.author | Lee, Hak Yeong | - |
dc.contributor.author | Kim, Gil Hyung | - |
dc.contributor.author | Park, Sun Young | - |
dc.contributor.author | Choi,Won Seok | - |
dc.contributor.author | Sohn, Uy Dong | - |
dc.date.accessioned | 2021-10-21T02:40:34Z | - |
dc.date.available | 2021-10-21T02:40:34Z | - |
dc.date.issued | 2021-05 | - |
dc.identifier.issn | 1976-9148 | - |
dc.identifier.issn | 2005-4483 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/50478 | - |
dc.description.abstract | In this study, we aimed to investigate the effects of 8 weeks of treatment with a combination of evogliptin and leucine, a branchedchain amino acid, in mice with high-fat diet (HFD)-induced diabetes. Treatment with evogliptin alone or in combination with leucine reduced the body weight of the mice, compared to the case for those from the HFD control group. Long-term treatment with evogliptin alone or in combination with leucine resulted in a significant reduction in glucose intolerance; however, leucine alone did not affect postprandial glucose control, compared to the case for the mice from the HFD control group. Furthermore, the combination of evogliptin and leucine prevented HFD-induced insulin resistance, which was associated with improved homeostasis model assessment for insulin resistance, accompanied by markedly reduced liver fat deposition, hepatic triglyceride content, and plasma alanine aminotransferase levels. The combination of evogliptin and leucine increased the gene expression levels of hepatic peroxisome proliferator-activated receptor alpha, whereas those of the sterol regulatory element-binding protein 1 and stearoyl-CoA desaturase 1 were not altered, compared to the case in the HFD-fed mice (p<0.05). Thus, our results suggest that the combination of evogliptin and leucine may be beneficial for treating patients with type 2 diabetes and hepatic steatosis; however, further studies are needed to delineate the molecular mechanisms underlying the action of this combination. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 한국응용약물학회 | - |
dc.title | Effects of the Combination of Evogliptin and Leucine on Insulin Resistance and Hepatic Steatosis in High-Fat Diet-Fed Mice | - |
dc.title.alternative | Effects of the Combination of Evogliptin and Leucine on Insulin Resistance and Hepatic Steatosis in High-Fat Diet-Fed Mice | - |
dc.type | Article | - |
dc.identifier.doi | 10.4062/biomolther.2021.003 | - |
dc.identifier.bibliographicCitation | Biomolecules & Therapeutics, v.29, no.4, pp 419 - 426 | - |
dc.identifier.kciid | ART002727218 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000668020200008 | - |
dc.identifier.scopusid | 2-s2.0-85110203031 | - |
dc.citation.endPage | 426 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 419 | - |
dc.citation.title | Biomolecules & Therapeutics | - |
dc.citation.volume | 29 | - |
dc.type.docType | Article | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Evogliptin | - |
dc.subject.keywordAuthor | Leucine | - |
dc.subject.keywordAuthor | High-fat diet | - |
dc.subject.keywordAuthor | Insulin resistance | - |
dc.subject.keywordPlus | DIPEPTIDYL-PEPTIDASE-IV | - |
dc.subject.keywordPlus | BETA-CELL FUNCTION | - |
dc.subject.keywordPlus | LIVER-DISEASE | - |
dc.subject.keywordPlus | INDUCED OBESITY | - |
dc.subject.keywordPlus | GLUCOSE | - |
dc.subject.keywordPlus | INHIBITOR | - |
dc.subject.keywordPlus | SITAGLIPTIN | - |
dc.subject.keywordPlus | METABOLISM | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.